Literature DB >> 17536621

Brief small intestinal ischemia lessens renal ischemia-reperfusion injury in rats.

Tao Song1, Ying-Fu Peng, Shi-Yin Guo, Yu-Hui Liu, Li-Ying Liul.   

Abstract

Ischemic preconditioning (IPC) not only reduces local tissue injury caused by subsequent ischemia-reperfusion (IR) but may also have a beneficial effect on IR injury of tissues remote from those undergoing preconditioning. In this study, we investigated the effect of small intestinal IPC on renal IR injury in rats. Renal IR injury was induced by a 45-min renal artery occlusion and reperfusion for 2 or 24 h in rats with a previous contralateral nephrectomy, and ischemic preconditioning was induced by 3 cycles of 8-min ischemia and 5-min reperfusion of the small intestine. We then measured the concentrations of plasma creatinine (Cr) and blood urine nitrogen (BUN) and the level of malondialdehyde (MDA) and activities of superoxide dismutase (SOD) and catalase (CAT) in the renal cortex. Renal histopathology also was evaluated. Pretreatment with intestinal ischemic preconditioning significantly alleviated renal IR injury, as shown by decreases in the levels of Cr, BUN, and MDA, decreased renal morphologic change, and improved preservation of SOD and CAT activities. These results suggest that remote ischemic preconditioning of the small intestine protects against renal IR injury by inhibition of lipid peroxidation and preservation of antioxidant enzyme activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536621

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  9 in total

1.  Protective effect of intestinal ischemic preconditioning on ischemia reperfusion-caused lung injury in rats.

Authors:  Zhidong Wang; Yuanyuan Ji; Shufeng Wang; Rong Wang; Zongfang Li; Anjing Kang; Huili Xu; Min Shi; MinXia Zhao
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 2.  Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?

Authors:  Natig Gassanov; Amir M Nia; Evren Caglayan; Fikret Er
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

Review 3.  Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Authors:  Carlos Rodrigo Camara-Lemarroy
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Remote Ischemic Preconditioning and Protection of the Kidney--A Novel Therapeutic Option.

Authors:  Alexander Zarbock; John A Kellum
Journal:  Crit Care Med       Date:  2016-03       Impact factor: 7.598

5.  No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators.

Authors:  Casper Kierulf-Lassen; Marie Louise Vindvad Kristensen; Henrik Birn; Bente Jespersen; Rikke Nørregaard
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 6.  Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review.

Authors:  Julio Palomino; Raquel Echavarria; Adriana Franco-Acevedo; Bibiana Moreno-Carranza; Zesergio Melo
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

7.  Evaluating the effect of remote ischemic preconditioning on kidney ischemia-reperfusion injury.

Authors:  Mahsan Samadi; Farinaz Tabibian; Kobra Moradzadeh; Seyed Mahdi Nassiri; Yousof Gheisari
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

8.  Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion.

Authors:  Amalia E Yanni; Eleutherios Margaritis; Nikolaos Liarakos; Alkisti Pantopoulou; Maria Poulakou; Maria Kostakis; Despoina Perrea; Alkis Kostakis
Journal:  Vasc Health Risk Manag       Date:  2008

9.  Remote ischemic conditioning for the prevention of contrast-induced acute kidney injury in patients undergoing intravascular contrast administration: a meta-analysis and trial sequential analysis of 16 randomized controlled trials.

Authors:  Chang-Cheng Zhou; Wen-Tao Yao; Yu-Zheng Ge; Lu-Wei Xu; Ran Wu; Xiao-Fei Gao; Kai-Wei Song; Xiao-Min Jiang; Min Wang; Wen-Juan Huang; Yun-Peng Zhu; Liang-Peng Li; Liu-Hua Zhou; Zhong-Le Xu; Sheng-Li Zhang; Jia-Geng Zhu; Wen-Cheng Li; Rui-Peng Jia
Journal:  Oncotarget       Date:  2017-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.